PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons
E-Collection

Related Articles
Retrospective: Producing Proteins the PSI:Biology Way
July 2015
Immunity: Conformational Capture
June 2014
Coaxing Rare Codons
February 2014
Caught in the Act
December 2013
Membrane Proteome: Tuning Membrane Protein Expression
December 2012
Membrane Proteome: Every Protein Has Its Tag
November 2012
Insert Here
October 2012
S is for solubility
June 2012
Overexpressed problems
February 2012
Gentle membrane protein extraction
January 2012
No more labeled lipids
May 2011
Five good reasons to use single protein production for membrane proteins
January 2010
One system to express them all
November 2009
Crystallizing glycoproteins
September 2009
GFP to the rescue
July 2009
Solve your solubility problems
June 2009
Tips for crystallizing membrane proteins
June 2009
Speedy cloning and mutagenesis for structural genomics
January 2009
Tuning membrane protein overexpression
October 2008

Technology Topics Protein Expression

Tuning membrane protein overexpression

PSI-SGKB [doi:10.1038/th_psisgkb.2008.9]
Technical Highlight - October 2008
Short description: Proc. Natl Acad. Sci. USA 105, 14371-14376 (2008)

Production of membrane proteins for in vitro experiments can be very difficult. Escherichia coli is the most commonly used organism for overexpression of recombinant proteins, and although high concentrations of recombinant membrane proteins can be achieved, they often end up in inclusion bodies.

Wagner et al. have a solution. They have engineered a strain of E. coli, called Lemo21(DE3), in which overexpression can be precisely controlled. With it they achieved high yields, not through ramping up overexpression levels in individual bacteria, but by ensuring good overall growth and ultimately a higher biomass than achieved with other strains.

In the commonly used E. coli strain BL21(DE3), the bacteriophage T7 RNA polymerase (T7RNAP) usually drives recombinant protein production. T7RNAP is in turn controlled by the strong promoter lacUV5. But most overexpressed membrane proteins end up in the cytoplasm and in aggregates, which are often toxic to the cell. The accumulations are thought to be because the Sec protein, which mediates the translocation and integration of secreted proteins across or into the cytoplasmic membrane, becomes swamped and stops working.

So Wagner et al. turned to the Walker strains of E. coli. These are known to produce a good yield of membrane protein, and the overexpressed proteins do not seem to be particularly toxic to the cell. But the reason for this was not clear.

Membrane protein overexpression in E. coli Lemo21(DE3) compared with five different commonly used E. coli strains with different concentrations of L-rhamnose (rha).

Analysis of Walker strains overexpressing the membrane protein YidC revealed the key mutations in the lacUV5 promoter that led to improved protein expression. Wagner et al. then used this information to engineer a BL21(DE3) derivative strain – Lemo21 (DE3) – in which activity of T7RNAP can be precisely controlled by its natural inhibitor T7 lysozyme (T7Lys). They put T7Lys under the control of an L-rhamnose-inducible promoter (rhaBAD), so that adding L-rhamnose in different amounts to the cultures resulted in different and scalable concentrations of YidC.

Use of Lemo21(DE3) should simplify membrane protein overexpression. It requires only a single strain and a simple titration of L-rhamnose and therefore could be well suited to high-throughput applications. Notably, ongoing studies indicate that Lemo21(DE3) also performs very well for the overexpression of 'difficult' soluble proteins.

Maria Hodges

References

  1. Samuel Wagner, Mirjam M Klepsch, Susan Schlegel, Ansgar Appel, Roger Draheim et al. Tuning Escherichia coli for membrane protein overexpression.
    Proc. Natl Acad. Sci. USA 105, 14371-14376 (2008). doi:10.1073/pnas.0804090105

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health